These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 36011877)
1. Agent Simulation Model of COVID-19 Epidemic Agent-Based on GIS: A Case Study of Huangpu District, Shanghai. Dong T; Dong W; Xu Q Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011877 [TBL] [Abstract][Full Text] [Related]
2. Modeling and interpreting the COVID-19 intervention strategy of China: A human mobility view. Chen H; He J; Song W; Wang L; Wang J; Chen Y PLoS One; 2020; 15(11):e0242761. PubMed ID: 33232385 [TBL] [Abstract][Full Text] [Related]
3. [Spatiotemporal changes of COVID-19 outbreak in Shanghai]. Fan JY; Shen JY; Hu M; Zhao Y; Lin JS; Cao GW Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Nov; 43(11):1699-1704. PubMed ID: 36444450 [No Abstract] [Full Text] [Related]
4. Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis. Tan C; Luo X; Zhou Z; Zeng X; Wan X; Yi L; Liu Q J Infect Public Health; 2023 Jun; 16(6):893-900. PubMed ID: 37062164 [TBL] [Abstract][Full Text] [Related]
5. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics. Kamel Boulos MN; Geraghty EM Int J Health Geogr; 2020 Mar; 19(1):8. PubMed ID: 32160889 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of prevention and control measures toward COVID-19 epidemic between Shanghai and Beijing. Meng Y; Wang X; Dong P; Yang Y; Wang K; Yan X; Hu G; Mao A; Qiu W Front Public Health; 2023; 11():1121846. PubMed ID: 37139394 [TBL] [Abstract][Full Text] [Related]
7. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective. Gao J; Zhang P Front Public Health; 2021; 9():756677. PubMed ID: 34976920 [No Abstract] [Full Text] [Related]
8. COVID-19 epidemic and public health interventions in Shanghai, China: Statistical analysis of transmission, correlation and conversion. Yi D; Chen X; Wang H; Song Q; Zhang L; Li P; Ye W; Chen J; Li F; Yi D; Wu Y Front Public Health; 2022; 10():1076248. PubMed ID: 36703835 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
10. The effectiveness of travel restriction measures in alleviating the COVID-19 epidemic: evidence from Shenzhen, China. Ji H; Tong H; Wang J; Yan D; Liao Z; Kong Y Environ Geochem Health; 2022 Sep; 44(9):3115-3132. PubMed ID: 33846892 [TBL] [Abstract][Full Text] [Related]
11. Optimal timing and effectiveness of COVID-19 outbreak responses in China: a modelling study. Zhang AZ; Enns EA BMC Public Health; 2022 Apr; 22(1):679. PubMed ID: 35392861 [TBL] [Abstract][Full Text] [Related]
12. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model. Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715 [TBL] [Abstract][Full Text] [Related]
13. Effect of Nucleic Acid Screening Measures on COVID-19 Transmission in Cities of Different Scales and Assessment of Related Testing Resource Demands-Evidence from China. Gao Q; Shang WP; Jing MX Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293923 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study. Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697 [TBL] [Abstract][Full Text] [Related]
15. Modeling COVID-19 transmission dynamics incorporating media coverage and vaccination. Wang X; Liang Y; Li J; Liu M Math Biosci Eng; 2023 Apr; 20(6):10392-10403. PubMed ID: 37322938 [TBL] [Abstract][Full Text] [Related]
16. Lessons drawn from Shanghai for controlling highly transmissible SARS-CoV-2 variants: insights from a modelling study. Wang H; Li T; Gao H; Huang C; Tang B; Tang S; Cheke RA; Zhou W BMC Infect Dis; 2023 May; 23(1):331. PubMed ID: 37194011 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 Prevention and Control Public Health Strategies in Shanghai, China. Zhang N; Shi T; Zhong H; Guo Y J Public Health Manag Pract; 2020; 26(4):334-344. PubMed ID: 32433388 [TBL] [Abstract][Full Text] [Related]
18. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607 [TBL] [Abstract][Full Text] [Related]
19. COMOKIT: A Modeling Kit to Understand, Analyze, and Compare the Impacts of Mitigation Policies Against the COVID-19 Epidemic at the Scale of a City. Gaudou B; Huynh NQ; Philippon D; Brugière A; Chapuis K; Taillandier P; Larmande P; Drogoul A Front Public Health; 2020; 8():563247. PubMed ID: 33072700 [TBL] [Abstract][Full Text] [Related]
20. [Transmission chains of local epidemic of COVID-19 caused by 2019-nCoV Delta variant in Zhenhai district, Ningbo]. Chen Y; Yan KD; Zhang DL; Yi B; Wang AH; Lei S; Hong H; Chu YR; Xu GZ Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jul; 43(7):1044-1048. PubMed ID: 35856197 [No Abstract] [Full Text] [Related] [Next] [New Search]